BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 37717785)

  • 1. Five-Day Spacing of Two Fractionated Ablative Radiotherapies Enhances Antitumor Immunity.
    Kim H; Lee E; Cho H; Kim E; Jang WI; Yang K; Lee YJ; Kim TJ; Kim MS
    Int J Radiat Oncol Biol Phys; 2024 Feb; 118(2):498-511. PubMed ID: 37717785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abscopal Effects With Hypofractionated Schedules Extending Into the Effector Phase of the Tumor-Specific T-Cell Response.
    Zhang X; Niedermann G
    Int J Radiat Oncol Biol Phys; 2018 May; 101(1):63-73. PubMed ID: 29534901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Antitumor Immune Response Is Evoked by Partial-Volume Single-Dose Radiation in 2 Murine Models.
    Markovsky E; Budhu S; Samstein RM; Li H; Russell J; Zhang Z; Drill E; Bodden C; Chen Q; Powell SN; Merghoub T; Wolchok JD; Humm J; Deasy JO; Haimovitz-Friedman A
    Int J Radiat Oncol Biol Phys; 2019 Mar; 103(3):697-708. PubMed ID: 30342090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiation dose and schedule influence the abscopal effect in a bilateral murine CT26 tumor model.
    Ghaffari-Nazari H; Alimohammadi M; Alimohammadi R; Rostami E; Bakhshandeh M; Webster TJ; Mahmoodi Chalbatani G; Tavakkol-Afshari J; Amir Jalali S
    Int Immunopharmacol; 2022 Jul; 108():108737. PubMed ID: 35417831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cisplatin and Albumin-Based Gold-Cisplatin Nanoparticles Enhance Ablative Radiation Therapy-Induced Antitumor Immunity in Local and Distant Tumor Microenvironment.
    Chen JL; Yang SJ; Pan CK; Lin LC; Tsai CY; Wang CH; Huang YS; Lin YL; Kuo SH; Shieh MJ
    Int J Radiat Oncol Biol Phys; 2023 Aug; 116(5):1135-1149. PubMed ID: 36792014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fractionated Radiation Severely Reduces the Number of CD8+ T Cells and Mature Antigen Presenting Cells Within Lung Tumors.
    Reijmen E; De Mey S; De Mey W; Gevaert T; De Ridder K; Locy H; Martens S; De Blay E; Bouwens L; Debie P; Breckpot K; De Grève J; De Ridder M; Goyvaerts C
    Int J Radiat Oncol Biol Phys; 2021 Sep; 111(1):272-283. PubMed ID: 33865948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting Myeloid-derived Suppressor Cells and Programmed Death Ligand 1 Confers Therapeutic Advantage of Ablative Hypofractionated Radiation Therapy Compared With Conventional Fractionated Radiation Therapy.
    Lan J; Li R; Yin LM; Deng L; Gui J; Chen BQ; Zhou L; Meng MB; Huang QR; Mo XM; Wei YQ; Lu B; Dicker A; Xue JX; Lu Y
    Int J Radiat Oncol Biol Phys; 2018 May; 101(1):74-87. PubMed ID: 29619980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NKTR-214 immunotherapy synergizes with radiotherapy to stimulate systemic CD8
    Walker JM; Rolig AS; Charych DH; Hoch U; Kasiewicz MJ; Rose DC; McNamara MJ; Hilgart-Martiszus IF; Redmond WL
    J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32457127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated.
    Demaria S; Ng B; Devitt ML; Babb JS; Kawashima N; Liebes L; Formenti SC
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):862-70. PubMed ID: 14967443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enlightening the Immune Mechanism of the Abscopal Effect in a Murine HCC Model and Overcoming the Late Resistance With Anti-PD-L1.
    Park JH; Kim HY; Lee A; Seo YK; Kim IH; Park ET; Kang MS; Park SJ; Park S
    Int J Radiat Oncol Biol Phys; 2021 Jun; 110(2):510-520. PubMed ID: 33383126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SMAC Mimetic Debio 1143 and Ablative Radiation Therapy Synergize to Enhance Antitumor Immunity against Lung Cancer.
    Tao Z; McCall NS; Wiedemann N; Vuagniaux G; Yuan Z; Lu B
    Clin Cancer Res; 2019 Feb; 25(3):1113-1124. PubMed ID: 30352911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gemcitabine selectively eliminates splenic Gr-1+/CD11b+ myeloid suppressor cells in tumor-bearing animals and enhances antitumor immune activity.
    Suzuki E; Kapoor V; Jassar AS; Kaiser LR; Albelda SM
    Clin Cancer Res; 2005 Sep; 11(18):6713-21. PubMed ID: 16166452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adding liposomal doxorubicin enhances the abscopal effect induced by radiation/αPD1 therapy depending on tumor cell mitochondrial DNA and cGAS/STING.
    Wang L; Luo R; Onyshchenko K; Rao X; Wang M; Menz B; Gaedicke S; Grosu AL; Firat E; Niedermann G
    J Immunother Cancer; 2023 Aug; 11(8):. PubMed ID: 37640480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulatory T Cells Shape the Differential Impact of Radiation Dose-Fractionation Schedules on Host Innate and Adaptive Antitumor Immune Defenses.
    Sia J; Hagekyriakou J; Chindris I; Albarakati H; Leong T; Schlenker R; Keam SP; Williams SG; Neeson PJ; Johnstone RW; Haynes NM
    Int J Radiat Oncol Biol Phys; 2021 Oct; 111(2):502-514. PubMed ID: 34023423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apatinib Combined with Local Irradiation Leads to Systemic Tumor Control via Reversal of Immunosuppressive Tumor Microenvironment in Lung Cancer.
    Liang LJ; Hu CX; Wen YX; Geng XW; Chen T; Gu GQ; Wang L; Xia YY; Liu Y; Fei JY; Dong J; Zhao FH; Ahongjiang Y; Hui KY; Jiang XD
    Cancer Res Treat; 2020 Apr; 52(2):406-418. PubMed ID: 31476848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of triple therapy with low-dose total body irradiation and hypo-fractionated radiation plus anti-programmed cell death protein 1 blockade on abscopal antitumor immune responses in breast cancer.
    Liu S; Liao Y; Chen Y; Yang H; Hu Y; Chen Z; Fu S; Wu J
    Int Immunopharmacol; 2023 Apr; 117():110026. PubMed ID: 36934673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PI3Kδ/γ inhibitor BR101801 extrinsically potentiates effector CD8
    Yoon YN; Lee E; Kwon YJ; Gim JA; Kim TJ; Kim JS
    J Immunother Cancer; 2022 Mar; 10(3):. PubMed ID: 35288465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PD-1 Restrains Radiotherapy-Induced Abscopal Effect.
    Park SS; Dong H; Liu X; Harrington SM; Krco CJ; Grams MP; Mansfield AS; Furutani KM; Olivier KR; Kwon ED
    Cancer Immunol Res; 2015 Jun; 3(6):610-9. PubMed ID: 25701325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor necrosis factor gene-engineered J558 tumor cell-released exosomes stimulate tumor antigen P1A-specific CD8+ CTL responses and antitumor immunity.
    Xie Y; Bai O; Zhang H; Li W; Xiang J
    Cancer Biother Radiopharm; 2010 Feb; 25(1):21-8. PubMed ID: 20187793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abscopal Effects of Radiotherapy Are Enhanced by Combined Immunostimulatory mAbs and Are Dependent on CD8 T Cells and Crosspriming.
    Rodriguez-Ruiz ME; Rodriguez I; Garasa S; Barbes B; Solorzano JL; Perez-Gracia JL; Labiano S; Sanmamed MF; Azpilikueta A; Bolaños E; Sanchez-Paulete AR; Aznar MA; Rouzaut A; Schalper KA; Jure-Kunkel M; Melero I
    Cancer Res; 2016 Oct; 76(20):5994-6005. PubMed ID: 27550452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.